CymaBay Therapeutics Presents Data at Digestive Disease Week 2020 Online Education
Data from previously completed open-label phase 2 study supports potential for seladelpar to improve pruritus (itching) in patients with PBCImprovements […]
Data from previously completed open-label phase 2 study supports potential for seladelpar to improve pruritus (itching) in patients with PBCImprovements […]
NEW YORK, June 19, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that […]
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive […]
CALGARY, Alberta, June 19, 2020 (GLOBE NEWSWIRE) — As previously announced by Delphi Energy Corp. (“Delphi” or the “Company”), the […]
TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX-V: LAB) (“LabGold” or the “Company”) is pleased to announce […]
LAVAL, Québec, June 19, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), […]
GREENVILLE, S.C., June 19, 2020 (GLOBE NEWSWIRE) — Delta Apparel, Inc. (NYSE American: DLA), a leading provider of core activewear […]
VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) […]
MONTREAL, June 19, 2020 (GLOBE NEWSWIRE) — Le Château Inc. (the “Company”) (TSX VENTURE: CTU) today provided an update on […]
Growth Capital To Fuel Surging Revenue Growth in 2020NEW YORK and TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — NexTech AR […]